×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
CHEN XIN [1]
CHEN MEIWAN [1]
CHOU CHON KIT [1]
Document Type
Journal article [2]
Date Issued
2022 [2]
Language
英語English [2]
Source Publication
Biomedicine and ... [1]
Chemical Enginee... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Amplified cancer immunotherapy of PD-L1 blockade by sequential tumor microenvironment reshaping and DC maturation
Journal article
Peng Hua, Di Jiang, Zhaopei Guo, Huayu Tian, Xuesi Chen, Meiwan Chen. Amplified cancer immunotherapy of PD-L1 blockade by sequential tumor microenvironment reshaping and DC maturation[J]. Chemical Engineering Journal, 2022, 453, 139795.
Authors:
Peng Hua
;
Di Jiang
;
Zhaopei Guo
;
Huayu Tian
;
Xuesi Chen
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
13.3
/
13.2
|
Submit date:2023/02/22
Cpg
Gene Carrier
Immunotherapy
Pd-l1
Quercetin
Small Hairpin Rna
Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells
Journal article
Chen, Shaokui, Li, Ruixin, Chen, Yibo, Chou, Chon Kit, Zhang, Zhexuan, Yang, Yang, Liao, Ping, Wang, Qingqing, Chen, Xin*. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells[J]. Biomedicine and Pharmacotherapy, 2022, 151, 113187.
Authors:
Chen, Shaokui
;
Li, Ruixin
;
Chen, Yibo
;
Chou, Chon Kit
;
Zhang, Zhexuan
; et al.
Favorite
|
TC[WOS]:
10
TC[Scopus]:
12
IF:
6.9
/
6.8
|
Submit date:2022/08/02
Cancer Immunotherapy
cd4+foxp3+ Regulatory t Cells
Cpg Oligodeoxynucleotide
Scutellarin
Tumor Necrosis Factor
Tumor Necrosis Factor Receptor Ii